Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vincristine × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 310 Other hematologic neoplasm 142 Sarcoma 33 CNS 32 Other solid neoplasm 17 Plasma cell 6 Myeloid 5 Genitourinary 4 Dermatologic 4 Gynecologic 3 Gastrointestinal 2 Other neoplasm 1 Other 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 354 Trastuzumab 343 Paclitaxel 300 Docetaxel 269 Capecitabine 234 Letrozole 216 Carboplatin 208 Doxorubicin 177 Tamoxifen 156 Radiotherapy 151 Fulvestrant 145 Epirubicin 144 Anastrozole 136 pembrolizumab 124 Surveys and Questionnaires 123 pertuzumab 113 Exercise 113 Vinorelbine 110 Magnetic Resonance Spectroscopy 108 exemestane 107 Bevacizumab 104 palbociclib 100 Blood Specimen Collection 96 Albumin-Bound Paclitaxel 87 Gemcitabine 84 Drug Therapy 84 130-nm albumin-bound paclitaxel 81 eribulin 79 pyrotinib 75 Cisplatin 69

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02299999 2025-01-15

SAFIR02_Breast

UNICANCER

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡